Progress and perspectives in primary mitochondrial myopathy: Highlights from the 2025 mitochondrial medicine masterclass with a focus on TK2 deficiency.
- DOI
- 10.1177/26330040261478640
- Published
- 2026 Jan-Dec
- Container
- Therapeutic advances in rare disease
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/26330040261478640,
title = {Progress and perspectives in primary mitochondrial myopathy: Highlights from the 2025 mitochondrial medicine masterclass with a focus on TK2 deficiency.},
author = {Larson A and Goettemoeller J and Goettemoeller K and Goettemoeller L and Goldstein A and Huggan N and Karaa A and Leahey M and Scaglia F and Yeske P and Zolkipli-Cunningham Z and Hirano M},
year = {2026},
journal = {Therapeutic advances in rare disease},
doi = {10.1177/26330040261478640},
url = {https://doi.org/10.1177/26330040261478640}
}RIS
TY - JOUR TI - Progress and perspectives in primary mitochondrial myopathy: Highlights from the 2025 mitochondrial medicine masterclass with a focus on TK2 deficiency. AU - Larson A AU - Goettemoeller J AU - Goettemoeller K AU - Goettemoeller L AU - Goldstein A AU - Huggan N AU - Karaa A AU - Leahey M AU - Scaglia F AU - Yeske P AU - Zolkipli-Cunningham Z AU - Hirano M PY - 2026 JO - Therapeutic advances in rare disease DO - 10.1177/26330040261478640 UR - https://doi.org/10.1177/26330040261478640 ER -
APA
A, L., J, G., K, G., L, G., A, G., N, H., A, K., M, L., F, S., P, Y., Z, Z., & M, H. (2026). Progress and perspectives in primary mitochondrial myopathy: Highlights from the 2025 mitochondrial medicine masterclass with a focus on TK2 deficiency.. Therapeutic advances in rare disease. https://doi.org/10.1177/26330040261478640
Source records
- pubmed · retrieved 2026-09-25T06:45:15.310Z